What's new? Log in Free sign up

National Research (NRC)

Company Profile

NRC Health is the leading provider of in-depth customer insights in healthcare.

Company profile

Ticker

NRC

Exchange

Website

CEO

Michael Hays

Incorporated

Location

Fiscal year end

Sector

Professional, Scientific, and Technical Services > Research and Development in Biotechnology

Industry (SIC)

Services - Commercial Physical & Biological Research

PPD • IQVIA • PRA Health Sciences • Syneos Health • Icon • Medpace • Charles River Laboratories International • Incyte • Zymergen • SomaLogic ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

National Research Corporation Canada ...

IRS number

470634000

NRC stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

3 Mar 23

Results of Operations and Financial Condition

Quarterly report

4 Nov 22

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Letter from SEC

Correspondence with SEC

Letter from SEC

Quarterly report

5 Aug 22

Results of Operations and Financial Condition

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Michael D. Hays

Change in insider ownership

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Change in insider ownership

Change in insider ownership

Change in insider ownership

Michael D. Hays

Financial summary

Financial statements Chart NRC financial data

Quarter (USD)	Dec 22	Sep 22	Jun 22	Mar 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	25.03 mm	25.03 mm	25.03 mm	25.03 mm	25.03 mm	25.03 mm
Cash burn (monthly)	1.12 mm	2.44 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	3.09 mm	6.74 mm	n/a	n/a	n/a	n/a
Cash remaining	21.93 mm	18.29 mm	n/a	n/a	n/a	n/a
Runway (months of cash)	19.5	7.5	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2022

NRC institutional ownership history Ownership history

87.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	114	107	+6.5%
Opened positions	13	5	+160.0%
Closed positions	6	6	–
Increased positions	43	39	+10.3%
Reduced positions	41	44	-6.8%

13F shares	Current	Prev Q	Change
Total value	379.44 bn	889.32 mm	+42566.0%
Total shares	21.62 mm	21.61 mm	+0.0%
Total puts	0.00	0.00
Total calls	400.00	0.00	NEW
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Amandla MK Trust	5.34 mm	$217.68 mm	-6.0%
Common Property Trust	4.77 mm	$245.79 mm	0.0%
Kayne Anderson Rudnick Investment Management	3.22 mm	$120.26 bn	-0.3%
BLK Blackrock	987.55 k	$36.84 bn	+5.9%
MS Morgan Stanley	974.25 k	$36.34 bn	+4323.8%
Vanguard	860.43 k	$32.09 bn	+1.1%
Conestoga Capital Advisors	727.75 k	$27.14 bn	-0.5%
Dimensional Fund Advisors	629.25 k	$23.47 mm	+0.1%
QV Investors	449.87 k	$16.78 mm	-3.1%
Renaissance Technologies	365.28 k	$13.74 bn	-7.1%

Largest transactions	Shares	Bought/sold	Change
Atlanta Capital Management Co L L C	0.00	-959.13 k	EXIT
MS Morgan Stanley	974.25 k	+952.23 k	+4323.8%
Amandla MK Trust	5.34 mm	-341.10 k	-6.0%
STT State Street	313.37 k	+313.37 k	NEW
Mawer Investment Management	0.00	-59.96 k	EXIT
BLK Blackrock	987.55 k	+54.63 k	+5.9%
BK Bank Of New York Mellon	130.19 k	+36.48 k	+38.9%
Renaissance Technologies	365.28 k	-27.80 k	-7.1%
Victory Capital Management	119.98 k	+18.57 k	+18.3%
Alpine Peaks Capital	35.36 k	-18.56 k	-34.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NRC insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
28 Feb 23	Karas Kevin R	Common Stock	Sell	Dispose S	No	No	45.3353	2,319	105.13 k	5,384
27 Feb 23	Karas Kevin R	Common Stock	Sell	Dispose S	No	No	45.5131	2,437	110.92 k	7,703
24 Feb 23	Karas Kevin R	Common Stock	Sell	Dispose S	No	No	45.8424	7,156	328.05 k	10,140
17 Feb 23	Amandla MK Trust	Common Stock	Sell	Dispose S	Yes	No	47.0372	4,253	200.05 k	4,405,234
16 Feb 23	Amandla MK Trust	Common Stock	Sell	Dispose S	Yes	No	47.023	1,952	91.79 k	4,409,487
7 Feb 23	Amandla MK Trust	Common Stock	Sell	Dispose S	Yes	No	47.03	100	4.70 k	4,411,439
2 Feb 23	Amandla MK Trust	Common Stock	Sell	Dispose S	Yes	No	47.335	100	4.73 k	4,411,539
9 Jan 23	Amandla MK Trust	Common Stock	Sell	Dispose S	Yes	No	40.7201	6,370	259.39 k	4,411,639

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Earnings Scheduled For February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Press releases

From Benzinga Pro

NRC Health offers first-of-its-kind patient experience EHR integration

LINCOLN, Neb., March 02, 2023 (GLOBE NEWSWIRE) -- NRC Health, the recognized leader and partner in patient experience improvement, is the first in the industry to seamlessly integrate patient-specific experience

Keys to delivering humanized care revealed in NRC Health's 2023 Experience Perspective

LINCOLN, Neb., Feb. 15, 2023 (GLOBE NEWSWIRE) -- NRC Health, the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, released its 2023 Experience

National Research Corporation Announces Fourth Quarter and Calendar Year 2022 Results

LINCOLN, Neb., Feb. 14, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter and calendar year 2022. Regarding the Company's 2022 annual

NRC Health recognized as Best in KLAS for Patient Experience Improvement

National Research Corporation Declares Quarterly Dividend

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.